ask="N/A"
ask_size="N/A"
average_daily_volume="43952"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="+0.61"
change_from_200_day_moving_average="0.24"
change_from_50_day_moving_average="-3.52"
change_from_52_week_high="-6.82"
change_From_52_week_low="9.52"
change_in_percent="+3.22%"
close="19.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="6898000"
high="19.81"
high_52_weeks="26.36"
last_trade_date="1/13/2017"
last_trade_price="19.54"
last_trade_size="1448"
last_trade_time="4:00pm"
low="18.31"
low_52_weeks="10.02"
market_capitalization="326.59M"
moving_average_200_day="19.30"
moving_average_50_day="23.06"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="18.91"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.22%"
percent_change_from_50_day_moving_average="-15.26%"
percent_change_from_52_week_high="-25.87%"
percent_change_from_52_week_low="+95.01%"
previous_close="18.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.64"
stock_exchange="NGM"
symbol="PTGX"
volume="19545"
weeks_range_52="10.02 - 26.36"
